Jefferson Researchers Find Chemotherapy and Radiation Together May Be Better for Patients with Locally Advanced Lung Cancer
(Published 9-1-2005) A new study led by lung cancer specialists at Jefferson Medical College adds to growing evidence that giving patients both chemotherapy and radiation in the beginning of treatment may help patients live longer. Non-small-cell lung cancer accounts for about 80 percent of all cases of lung cancer. An estimated 40,000 Americans are diagnosed each year with locally advanced disease.

Trial at Jefferson Shows New Drug May Help Cancer Patients in Need of Stem Cell Transplants
(Published 9-7-2005) A new drug may help cancer patients mobilize the cells necessary to restore their blood-forming system after high-dose chemotherapy, according to results from a clinical trial at the Kimmel Cancer Center at Thomas Jefferson University Hospital in Philadelphia and at other centers across the nation.

Johns Hopkins Pancreas Specialist and Alimentary Tract Surgeon Joins Jefferson as Chair of Surgery
(Published 9-12-2005) Preeminent pancreatic cancer surgeon Charles J. Yeo, M.D., has been selected as the new Samuel D. Gross Professor and Chair of Surgery at Jefferson Medical College of Thomas Jefferson University and at Thomas Jefferson University Hospital, Philadelphia.

Philadelphia Eagles Announce Partnership with Jefferson University Hospital
(Published 9-15-2005) The Philadelphia Eagles are proud to announce a new partnership with Thomas Jefferson University Hospital and a medical services agreement with the physicians at the Rothman Institute at Jefferson.

Jefferson Study to Evaluate Impact of Procedure in Preventing Premature Birth
(Published 9-19-2005) Physicians in the Maternal-Fetal Medicine Program at Thomas Jefferson University Hospital are participating in a nationwide study to learn if cerclage--a “stitch” placed at the base of a woman’s cervix to ensure that it is kept closed during pregnancy--is beneficial in delaying or preventing preterm or premature birth in those women with a history of prior premature birth.

Understanding IGF-1: Jefferson Researcher Sees Drug Potential in Targeting Protein
(Published 9-19-2005) According to Dr. Baserga, who is professor of microbiology and immunology at Jefferson Medical College of Thomas Jefferson University in Philadelphia and acting director of Jefferson’s Kimmel Cancer Center, in the past few years, scientists have learned that the IGF-1 receptor is also a key growth factor that regulates cell and body size.

Do You Have a Problem Sleeping Through the Night? Jefferson Researchers Say ‘Don’t Rule out Reflux’
(Published 9-21-2005) In a prospective study designed to determine whether people who can’t get a good night’s sleep have a problem that is not related to sleeping, researchers at Jefferson Medical College have found that many of these people may be awakened from their sleep by gastroesophageal reflux (GERD).

Jefferson Scientists Design Method to Fight Artificial Implant Infections with Antibiotics
(Published 9-23-2005) Infections associated with inserting a medical device can be devastating, painful, and cause prolonged disability, costing tens of thousands of dollars. Now, researchers at Jefferson Medical College have found a way to create a permanent chemical bond between antibiotics and titanium, a material used in orthopedic implants. The proof-of-principle study showed that an antibiotic can be connected to the titanium surface in an active form, and can kill bacteria and prevent infection. The work is a critical first step toward developing stable, bacteria-resistant implants to combat infection.

Thomas Jefferson University Hospital Honors Philanthropist Dorrance H. Hamilton and Past Jefferson Surgery Chair Francis E. Rosato at 127th Anniversary Gala
(Published 9-26-2005) Thomas Jefferson University Hospital will honor surgeon Francis E. Rosato, M.D., and philanthropist Dorrance H. “Dodo” Hamilton for their dedication to Jefferson at the hospital’s 127th anniversary gala. The Anniversary Gala will take place Thursday evening, Oct. 6, at the Park Hyatt Hotel at the Bellevue in Philadelphia.

Cristina G. Cavalieri, J.D., BSN, Named Vice President and University Counsel at Thomas Jefferson University
(Published 9-30-2005) Cristina G. Cavalieri, J.D., BSN has been named vice president and university counsel at Thomas Jefferson University, Philadelphia. She joins Jefferson from the law firm of Pelino & Lentz, P.C. where she was a partner and chair of its health care department. Ms. Cavalieri was also active in governmental relations.